Alterations in lung and skin compositions of rat in bleomycin-induced fibrosis. 1987

L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
Biological Laboratory, Central Leather Research Institute, Madras, India.

Male albino rats were given bleomycin subcutaneously (5 mg potency/kg body weight twice a week) for a period of 6 weeks. At this dosage, mortality was found to be nil with marked fibrotic changes. Pulmonary and cutaneous changes at the end of 2, 4, and 6 weeks of treatment were investigated both by light microscopy and analyses of the intra- and extracellular components. Histologically, fibrosis set in as early as 2 weeks of treatment with bleomycin and was pronounced with increasing duration of treatment. Biochemically, total collagen and hexosamine contents of lung and skin increased significantly compared to control toward the end of treatment period. Thus, this animal model can be conveniently used to mimic the human condition and to test effective antifibrotic agents.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006595 Hexosamines AMINO SUGARS created by adding an amine group to a hexose sugar. Hexosamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
July 1985, The Journal of clinical investigation,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
March 2024, Reumatismo,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
February 2022, Experimental and molecular pathology,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
August 2023, Arthritis research & therapy,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
March 2021, International journal of molecular sciences,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
June 2012, The Journal of thoracic and cardiovascular surgery,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
October 2021, Clinical rheumatology,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
September 1985, Toxicology letters,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
November 1999, American journal of respiratory and critical care medicine,
L Chandrasekaran, and S Seethalakshmi, and G Chandrakasan, and S C Dhar
January 2008, PloS one,
Copied contents to your clipboard!